|This Slide: #20 of 100|
Slide #20. Forest Laboratories — Furiex Pharmaceuticals
Forest Laboratories (FRX)
Forest Laboratories, Inc. (NYSE:FRX) will hold a conference call with investors at 9:30 AM EST today to discuss the details of this morning's announcement that Forest has entered into a definitive agreement to acquire Furiex, a drug development collaboration company. Note that the call time has been changed from 8:30 AM EST.
Forest Laboratories is a pharmaceutical company that develops, manufactures, and sells branded forms of drug products, most of which require a physician's prescription. Co.'s primary products in the U.S. are marketed directly, or detailed, to physicians by its salesforces. Co. also focuses on the development and introduction of new products, including products developed in collaboration with its licensing partners. Co.'s products include those developed by Co., those developed in conjunction with its partners and those acquired from other pharmaceutical companies and integrated into its marketing and distribution systems.
Open the FRX Page at The Online Investor »
Hold (2.47 out of 4)
(ranked higher than approx. 96% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite